Literature DB >> 25410877

Deletion mutants of Schmallenberg virus are avirulent and protect from virus challenge.

Franziska Kraatz1, Kerstin Wernike1, Silke Hechinger1, Patricia König1, Harald Granzow2, Ilona Reimann1, Martin Beer3.   

Abstract

UNLABELLED: Since its emergence, Schmallenberg virus (SBV), a novel insect-transmitted orthobunyavirus which predominantly infects ruminants, has caused a large epidemic in European livestock. Newly developed inactivated vaccines are available, but highly efficacious and safe live vaccines are still not available. Here, the properties of novel recombinant SBV mutants lacking the nonstructural protein NSs (rSBVΔNSs) or NSm (rSBVΔNSm) or both of these proteins (rSBVΔNSs/ΔNSm) were tested in vitro and in vivo in type I interferon receptor knockout mice (IFNAR(-/-)) and in a vaccination/challenge trial in cattle. As for other bunyaviruses, both nonstructural proteins of SBV are not essential for viral growth in vitro. In interferon-defective BHK-21 cells, rSBVΔNSs and rSBVΔNSm replicated to levels comparable to that of the parental rSBV; the double mutant virus, however, showed a mild growth defect, resulting in lower final virus titers. Additionally, both mutants with an NSs deletion induced high levels of interferon and showed a marked growth defect in interferon-competent sheep SFT-R cells. Nevertheless, in IFNAR(-/-) mice, all mutants were virulent, with the highest mortality rate for rSBVΔNSs and a reduced virulence for the NSm-deleted virus. In cattle, SBV lacking NSm caused viremia and seroconversion comparable to those caused by the wild-type virus, while the NSs and the combined NSs/NSm deletion mutant induced no detectable virus replication or clinical disease after immunization. Furthermore, three out of four cattle immunized once with the NSs deletion mutant and all animals vaccinated with the virus lacking both nonstructural proteins were fully protected against a challenge infection. Therefore, the double deletion mutant will provide the basis for further developments of safe and efficacious modified live SBV vaccines which could be also a model for other viruses of the Simbu serogroup and related orthobunyaviruses. IMPORTANCE: SBV induces only mild clinical signs in adult ruminants but causes severe fetal malformation and, thereby, can have an important impact on animal welfare and production. As SBV is an insect-transmitted pathogen, vaccination will be one of the most important aspects of disease control. Here, mutant viruses lacking one or two proteins that essentially contribute to viral pathogenicity were tested as modified live vaccines in cattle. It could be demonstrated that a novel recombinant double deletion mutant is a safe and efficacious vaccine candidate. This is the first description of a putative modified live vaccine for the complete genus Orthobunyavirus, and in addition, such a vaccine type has never been tested in cattle for any virus of the entire family Bunyaviridae. Therefore, the described vaccine also represents the first model for a broad range of related viruses and is of high importance to the field.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25410877      PMCID: PMC4300748          DOI: 10.1128/JVI.02729-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase.

Authors:  M Geiser; R Cèbe; D Drewello; R Schmitz
Journal:  Biotechniques       Date:  2001-07       Impact factor: 1.993

2.  Efficient bunyavirus rescue from cloned cDNA.

Authors:  Anice C Lowen; Carol Noonan; Angela McLees; Richard M Elliott
Journal:  Virology       Date:  2004-12-20       Impact factor: 3.616

3.  Pathogenicity of different strains of Akabane virus for mice.

Authors:  H Kurogi; Y Inaba; E Takahashi; K Sato; H Akashi; K Satoda; T Omori
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1978

4.  Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs.

Authors:  Gjon Blakqori; Friedemann Weber
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Reversion to virulence of chicken-passaged infectious bronchitis vaccine virus.

Authors:  S R Hopkins; H W Yoder
Journal:  Avian Dis       Date:  1986 Jan-Mar       Impact factor: 1.577

6.  A RNA virus in cells from Culicoides variipennis.

Authors:  S J Wechsler; L E McHolland; W C Wilson
Journal:  J Invertebr Pathol       Date:  1991-03       Impact factor: 2.841

7.  Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.

Authors:  U J Buchholz; S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Schmallenberg Virus in Culicoides Biting Midges in the Netherlands in 2012.

Authors:  A R W Elbers; R Meiswinkel; E van Weezep; E A Kooi; W H M van der Poel
Journal:  Transbound Emerg Dis       Date:  2013-07-24       Impact factor: 5.005

9.  Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death.

Authors:  Alain Kohl; Reginald F Clayton; Friedemann Weber; Anne Bridgen; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Functional role of type I and type II interferons in antiviral defense.

Authors:  U Müller; U Steinhoff; L F Reis; S Hemmi; J Pavlovic; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

View more
  20 in total

1.  Characterization of the Gamboa Virus Serogroup (Orthobunyavirus Genus, Peribunyaviridae Family).

Authors:  Jannifer Oliveira Chiang; William Marciel de Souza; Márcio Roberto Teixeira Nunes; Gustavo Olszanski Acrani; Amélia Paes de Andrade Travassos da Rosa; Nelma Mesquita de Freitas; Sandro Patroca da Silva; Pedro Henrique Dorta da Silva; Alana Watanabe de Sousa; Sueli Guerreiro Rodrigues; Juarez Antônio Simões Quaresma; Bedsy Dutary; Hilda Guzmán; Nikos Vasilakis; Robert B Tesh; Pedro Fernando da Costa Vasconcelos
Journal:  Am J Trop Med Hyg       Date:  2018-02-08       Impact factor: 2.345

2.  Characterization of Shuni viruses detected in Israel.

Authors:  Natalia Golender; Kerstin Wernike; Velizar Bumbarov; Andrea Aebischer; Alexander Panshin; Maria Jenckel; Yevgeny Khinich; Martin Beer
Journal:  Virus Genes       Date:  2016-08-19       Impact factor: 2.332

3.  A broad spectrum screening of Schmallenberg virus antibodies in wildlife animals in Germany.

Authors:  Susan Mouchantat; Kerstin Wernike; Walburga Lutz; Bernd Hoffmann; Rainer G Ulrich; Konstantin Börner; Ulrich Wittstatt; Martin Beer
Journal:  Vet Res       Date:  2015-09-23       Impact factor: 3.683

4.  Persistence of the protective immunity and kinetics of the isotype specific antibody response against the viral nucleocapsid protein after experimental Schmallenberg virus infection of sheep.

Authors:  Antoine Poskin; Stephanie Verite; Loic Comtet; Yves Van der Stede; Brigitte Cay; Nick De Regge
Journal:  Vet Res       Date:  2015-10-15       Impact factor: 3.683

5.  Nonstructural Protein NSs of Schmallenberg Virus Is Targeted to the Nucleolus and Induces Nucleolar Disorganization.

Authors:  Julie Gouzil; Aurore Fablet; Estelle Lara; Grégory Caignard; Marielle Cochet; Cindy Kundlacz; Massimo Palmarini; Mariana Varela; Emmanuel Breard; Corinne Sailleau; Cyril Viarouge; Muriel Coulpier; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

6.  The N-terminal domain of Schmallenberg virus envelope protein Gc is highly immunogenic and can provide protection from infection.

Authors:  Kerstin Wernike; Andrea Aebischer; Gleyder Roman-Sosa; Martin Beer
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

7.  Mutations in the Schmallenberg Virus Gc Glycoprotein Facilitate Cellular Protein Synthesis Shutoff and Restore Pathogenicity of NSs Deletion Mutants in Mice.

Authors:  Mariana Varela; Rute Maria Pinto; Marco Caporale; Ilaria M Piras; Aislynn Taggart; Frauke Seehusen; Kerstin Hahn; Anna Janowicz; William Marciel de Souza; Wolfgang Baumgärtner; Xiaohong Shi; Massimo Palmarini
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

8.  Development of reverse genetics systems and investigation of host response antagonism and reassortment potential for Cache Valley and Kairi viruses, two emerging orthobunyaviruses of the Americas.

Authors:  James I Dunlop; Agnieszka M Szemiel; Aitor Navarro; Gavin S Wilkie; Lily Tong; Sejal Modha; Daniel Mair; Vattipally B Sreenu; Ana Da Silva Filipe; Ping Li; Yan-Jang S Huang; Benjamin Brennan; Joseph Hughes; Dana L Vanlandingham; Stephen Higgs; Richard M Elliott; Alain Kohl
Journal:  PLoS Negl Trop Dis       Date:  2018-10-29

Review 9.  Schmallenberg virus infection of ruminants: challenges and opportunities for veterinarians.

Authors:  François Claine; Damien Coupeau; Laetitia Wiggers; Benoît Muylkens; Nathalie Kirschvink
Journal:  Vet Med (Auckl)       Date:  2015-06-29

10.  Comparison of Schmallenberg virus sequences isolated from mammal host and arthropod vector.

Authors:  Julia Kęsik-Maliszewska; Aleksandra Antos; Jerzy Rola; Magdalena Larska
Journal:  Virus Genes       Date:  2018-10-19       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.